Could a nausea drug help fight COVID-19? early trial cut short
Disease control
Terminated
This phase 2 trial tested whether adding aprepitant, a drug usually used for nausea, to standard care could help hospitalized COVID-19 patients recover faster. The study planned to enroll adults recently admitted to the hospital with COVID-19 and signs of lung involvement. Howeve…
Phase: PHASE2 • Sponsor: Heron Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC